Huixia Cao
发表
F. Shao,
Lei Yan,
Hui-xia Cao,
2020,
International immunopharmacology.
F. Shao,
Lei Yan,
Hui-xia Cao,
2019,
Biochemical and biophysical research communications.
Lei Jin,
Xu Dong Zhang,
R. Thorne,
2021,
Theranostics.
Lei Jin,
Xu Dong Zhang,
R. Thorne,
2021
.
Xiaojing Jiao,
Lina Zhang,
Yanliang Wang,
2024,
Ecotoxicology and Environmental Safety.
Lei Yan,
Xiaojing Jiao,
Yanliang Wang,
2024,
Scientific reports.
F. Shao,
Lei Yan,
Hui-xia Cao,
2021,
OncoTargets and therapy.
Ting La,
Li Wang,
L. Teng,
2024,
Clinical and translational medicine.
Benjamin S. Freedman,
Steven L. Chang,
A. Kibel,
2017,
Kidney international.
Yun Ding,
Yanfang Lu,
F. Shao,
2022,
Cells.
Lei Jin,
Xu Dong Zhang,
R. Thorne,
2023,
Advanced science.
F. Shao,
Guodong Li,
Na Li,
2021,
The Journal of Immunology.
F. Shao,
Yuan Ma,
Lei Yan,
2020,
Bioorganic chemistry.
F. Shao,
Yun Ding,
Song Chen,
2022,
Ecotoxicology and environmental safety.
F. Shao,
Hong Zhang,
Hui-xia Cao,
2018,
International immunopharmacology.
Zhenhua Zhang,
Hui-xia Cao,
Wei Wang,
2021,
Cellular signalling.
The pan-cancer lncRNA PLANE regulates an alternative splicing program to promote cancer pathogenesis
S. Guo,
Xu Dong Zhang,
R. Thorne,
2020,
Nature Communications.